NEWS

Pharmaceutical Industry news helps our clients to give competitive edge to their customers and also latest pharmaceutical industry news assists them in gaining updated knowledge. We bring you Global Pharmaceutical news about acquisitions, project undertakings, business and marketing, subjects, and industry related subjects, written in a professional, unbiased and thought-provoking format. Our international pharmaceutical News will help you enhance your business knowledge and productivity.

New Jersey Innovation Institute (NJII), a New Jersey Institute of Technology (NJIT) Corporation, has signed an Industry Participation Agreement with Pall Corporation (Pall) to support the development of its BioPharmaceutical Innovation iLab. The partnership will support two key Centers at NJII that will advance the manufacturing of new cell and…

ValoremRx Specialty Solutions, the group purchasing organization (GPO) formed by a joint venture between Express Scripts and Walgreens, today announced its new collaboration with Kroger Specialty Pharmacy. Partnered with Express Scripts' specialty pharmacy Accredo® and Walgreens' specialty pharmacy affiliates including AllianceRx Walgreens Prime, Kroger Specialty Pharmacy becomes the third participant…

Pascal Biosciences Inc., a drug discovery and development company, today announced a partnership with Mitacs for a multi-year cancer research project at the University of British Columbia (UBC).  Mitacs, a not-for-profit organization that fosters growth and innovation, will provide equal funding for research efforts at UBC that will directly support…

PDS Biotechnology Corporation (“PDS Biotechnology”), a clinical-stage immuno-oncology company pioneering the development of novel multifunctional immunotherapeutic products, today announced the closing of its merger with Edge Therapeutics, Inc. (“Edge”), following the approval of Edge stockholders on March 14, 2019. Following the merger, Edge will operate as “PDS Biotechnology Corporation” and…

Enigma Biomedical Group (EBG) today announced an exclusive license agreement with Merck, known as MSD outside the US and Canada, for the global development and commercialization of MK-6884, an early stage investigational imaging agent developed by Merck for use in Positron Emission Tomography (PET) scans to measure cholinergic tone change…

Blackstone announced today that private equity funds managed by Blackstone (“Blackstone”) have entered into a definitive agreement to acquire AYUMI Pharmaceutical Corporation (“AYUMI” or “the Company”), a leading specialty pharmaceutical company in Japan focused on Anti-Rheumatism and Orthopedics, from Unison Capital, an independent private equity firm based in Japan, and…

BioLife Solutions, Inc today announced that it has entered into an agreement to acquire Astero Bio Corporation ("Astero"), a privately-held innovator in the design, development and commercialization of novel automated thawing devices, for an upfront cash payment of $8.0 million.  This transaction is expected to further strengthen BioLife's position as…

AbCellera today announced a two-year agreement with the Bill & Melinda Gates Foundation to help accelerate global health research. The funding, totaling $4.8 M, will support a series of scientific collaborations between AbCellera and Gates Foundation-funded scientists working on the prevention and treatment of high-priority infectious diseases. The target diseases…

Flow Pharma Inc. , a biotechnology company focused on the development of personalized vaccines against cancer, based in the San Francisco Bay Area, today announced a collaboration with the company of Norwegian bioinformatics OncoImmunity AS . The agreement signed with OncoImmunity provides for the license to use the Immuneoprofiler ™…

The U.S. Food and Drug Administration said on Tuesday it had approved a new generic version of blood pressure medicine valsartan, as the agency looks to ease shortages triggered by several manufacturers recalling the drug over possible cancer risk. Drugmakers, including Teva Pharmaceutical Industries Ltd and Mylan NV, have pulled…

loadmore..